**Correction**
A subheading in the press release sent yesterday was incorrect - the line 'Global rates of diabetes doubled over the last two decades' should be ''Global rates of diabetes doubled over the last three decades'.
The subheading and two further occurrences of the same mistake have been corrected in the copy below (in yellow). The rest of the press release remains unchanged.
We sincerely apologise for any inconvenience caused,
The Lancet press office ([email protected]).
The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests
· The global rate of diabetes (type 1 and 2 combined) in adults doubled from approximately 7% to about 14% between 1990 to 2022, with the largest increase in low- and middle-income countries (LMICs).
· Over the same period, rates of treatment for diabetes stagnated at low levels in many of the same LMICs where rates of the disease have drastically increased, resulting in almost 450 million adults aged 30 and over with diabetes globally (59%) who did not receive treatment in 2022.
· Meanwhile, people living in North America, Australasia, central and western Europe, and parts of Latin America and East Asia and the Pacific saw a significant improvement in treatment rates for diabetes from 1990 to 2022, contributing to widening global inequities in diabetes treatment.
· Authors say the study highlights the urgent need for financing of medicines and comprehensive diabetes programmes that enable early detection and effective treatment of diabetes in LMICs.
